‘Think critically’: Caution key in assessing clinical trial data

HUNTINGTON BEACH, Calif. — Rheumatologists should exercise caution in interpreting clinical trial results, with a particular awareness of potential errors and confounders, said a presenter at the Congress of Clinical Rheumatology West.
“Think critically when interpreting trial results and be careful not to over-interpret the delta between the active and placebo arms,” Andreas Kerschbaumer, MD, PhD, a postdoctoral scholar in the division of immunology and rheumatology at Stanford University, told Healio in an interview. “Study design, where a trial recruited, and